<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>HNN215 Week 5 12pm by </title>
      <link>https://padlet.com/sarahd59/pkcedzez5nocz4py</link>
      <description>Management of patients experiencing respiratory symptoms</description>
      <language>en-us</language>
      <pubDate>2023-08-06 05:16:06 UTC</pubDate>
      <lastBuildDate>2023-08-09 23:24:28 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>Compare and contrast the mode of action of the drug classes</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620428</link>
         <description><![CDATA[<div>Did you find a simpler way to describe them?<br>Could you say in your own words what they are?<br>Did you need to go and look them up again? Do you need to rethink your explanation into your own words?</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620428</guid>
      </item>
      <item>
         <title>Case scenario</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620429</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/07f38be805f2a200c56984adf9c338cb/image.png" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620429</guid>
      </item>
      <item>
         <title>Scenario continued</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620430</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/6df8a3965b80cfa1c344cdb870e329c2/image.png" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620430</guid>
      </item>
      <item>
         <title>Significant risks / drug-drug interactions???</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620431</link>
         <description><![CDATA[<div>How / why does it occur?<br>What are they and what signs and symptoms would we see?<br>What do we as nurses do;<br>- prevent and/ or manage these?</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/782a2d3ed595ab32aedfc203b4dc0822/image.png" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620431</guid>
      </item>
      <item>
         <title></title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620432</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/3fd7bcfb6252ed71598cacd105c88ac1/HNN215_week_5_NIMC_2023.pdf" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620432</guid>
      </item>
      <item>
         <title>Consider???</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620433</link>
         <description><![CDATA[<div><strong><mark>Note: Always consider:<br>Is there anything in the patient's condition/ past history that may increase the risks?</mark></strong></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620433</guid>
      </item>
      <item>
         <title>Group 1</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620434</link>
         <description><![CDATA[<div>Salbutamol<br>CLASS: Beta2 Agonist (short acting) <br>MOA: relax bronchial smooth muscle by stimulating beta2 adrenoreceptors <br>Indications for use: Asthma and COPD<br>prevention of exercise induce bronchocconstriction <br>Drug interactions: Serious hypokalaemia may occur with high doses of beta<sub>2</sub> agonists; may be worsened by theophyllines, corticosteroids, diuretics and hypoxia.<br>Signs &amp; Symptoms: tremor, palpitations, headache (Salbutamol toxicity)<br>Nursing considerations to prevent, assess or manage risks:<br>Cardiovascular disorders-risk of adverse effects, check inhaler/spacer techniques to insure being used correctly,&nbsp; review management of asthma if high or increasing use of SABAs can indicate poor asthma management&nbsp;<br>Diabetes- monitor BGL risk of hyperglycemia .</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620434</guid>
      </item>
      <item>
         <title>Group 1</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620435</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620435</guid>
      </item>
      <item>
         <title>Group 2</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620436</link>
         <description><![CDATA[<div>Seretide<br>CLASS:&nbsp; Corticosteroid -&nbsp; &nbsp; &nbsp; &nbsp; Inhaled (ICS)&nbsp;</div><div><br>MOA:&nbsp; &nbsp;<br>-&nbsp; &nbsp; &nbsp; &nbsp; Enters the cell <br>-&nbsp; &nbsp; &nbsp; &nbsp; Enters the nucleus of the cell <br>-&nbsp; &nbsp; &nbsp; &nbsp; Increases or decreases the synthesis of specific proteins including those in enzymes that regulate cell inflammation.<br><br>Indications for use: asthma and COPD in people who need regular treatment<br><br>Drug interactions: <br>- avoid using with high-dose aspirin<br>- avoid using with NSAIDs<br>- avoid using with warfarin<br><br>Signs &amp; Symptoms:&nbsp; Dysphonia, oral pharyngeal candiasis, bruising<br>Nursing considerations to prevent, assess or manage risks:<br>- Monitor obs regularly<br>- Perform a physical examination to establish baseline data for assessing the effectiveness of the drug and the occurrence of any adverse effects associated with drug therapy.<br>- <em>COPD</em>—inhaled corticosteroids may increase the risk of pneumonia.<br>- <em>Smoking</em>—asthma patients who smoke may respond less well to inhaled corticosteroids than non-smokers and may require higher doses.<br>- Cover eyes during nebulisation and was face afterwards. If possible use mouthpiece rather than mask to reduce risk of facial irritation. rinse mouth after use.<br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620436</guid>
      </item>
      <item>
         <title>Group 2</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620437</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620437</guid>
      </item>
      <item>
         <title>Group 3</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620438</link>
         <description><![CDATA[<div>Prednisolone<br>CLASS:<br>MOA:<br>Indications for use:&nbsp;<br>Drug interactions:<br>Signs &amp; Symptoms:<br>Nursing considerations to prevent, assess or manage risks:</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620438</guid>
      </item>
      <item>
         <title>Group 3</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620439</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620439</guid>
      </item>
      <item>
         <title>Group 4</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620440</link>
         <description><![CDATA[<div><strong>Ipratropium: </strong><br><br><strong>CLASS: </strong>Anticholinergics<br><br><strong>MOA: </strong>Promote bronchodilation by inhibiting cholinergic bronchomotor tone and prevent muscarinic actions of acetylcholine.<br><br><strong>Indications for use: </strong>Symptom relief of asthma and COPD. <br><br><strong>Drug interactions: </strong><br>- Avoid using with any other anticholinergic drugs. <br>- The risk or severity of reduced gastrointestinal motility can be increased when <strong><em>Pramlintide</em></strong> is combined with <strong><em>Ipratropium</em></strong>.<br><br><strong>Signs &amp; Symptoms:</strong><br>Headache<br>Nausea<br>Taste disturbance<br>Dry mouth<br>Throat irritation. <br><br><strong>Nursing considerations to prevent, assess or manage risks:<br>- </strong>Do not allow the powder or mist to come into contact with your eyes/Contact a doctor if there is any eye discomfort or impacted vision.&nbsp;<br>- Long-acting anticholinergics: do not use for immediate relief of symptoms.<br>- Not recommended for long-term use.&nbsp;</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620440</guid>
      </item>
      <item>
         <title>Group 4</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620441</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620441</guid>
      </item>
      <item>
         <title>Group 5</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620442</link>
         <description><![CDATA[<div>Nystatin<br><strong>CLASS:</strong> Anti-infectives/Anti-fungals - polyene<br><br><strong>MOA: </strong>It binds to ergosterol in fungal cell membranes altering their permeability and allowing leakage of intracellular components.<br><br></div><div><strong>Indications for use: </strong><br>- Oropharyngeal candidiasis (thrush)<br>- Treatment and suppression of intestinal candidiasis<br>- Vulvovaginal candidiasis</div><div><br><strong>Drug interactions:</strong><br>- May change how your medications work or increase risk of serious side effects<br><br><strong>Signs &amp; Symptoms:</strong><br>- GIT - nausea, vomiting &amp; diarrhoea<br><br></div><div><strong>Nursing considerations to prevent, assess or manage risks:</strong><br>- For a oropharyngeal infection - use oral liquid after a meal or drink. Swish the liquid around the mouth for as long as comfortable before swallowing.<br>- Education - Continue to use for several days even after your symptoms disappear.<br><br></div><div><strong>Practice points:</strong><br>- oral liquid is effective in the Tx for minor oral fungal infections<br>- Tx with oral itraconazole or fluconazole is often required in immunocompromised people - such as those with HIV<em><br></em><br></div><div><br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620442</guid>
      </item>
      <item>
         <title>Group 5</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620443</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620443</guid>
      </item>
      <item>
         <title>What are you going to give Noah right now for his dyspnoea??</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620444</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620444</guid>
      </item>
      <item>
         <title>Paediatric patients and medications</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620445</link>
         <description><![CDATA[<div>What factors may result in impaired medication effects in these patients?</div>]]></description>
         <enclosure url="https://image.slideserve.com/1208289/clinical-pharmacokinetics-l.jpg" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620445</guid>
      </item>
      <item>
         <title>Group 1</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620446</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620446</guid>
      </item>
      <item>
         <title>Group 2</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620447</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620447</guid>
      </item>
      <item>
         <title>Group 3</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620448</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620448</guid>
      </item>
      <item>
         <title>Group 4</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620449</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620449</guid>
      </item>
      <item>
         <title>Medication administration considerations</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620450</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/6aa2f8be7eb78b4f9d8553c73d641f40/image.png" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620450</guid>
      </item>
      <item>
         <title>Additional resources</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620451</link>
         <description><![CDATA[<div>The junior version has a green barrel<br>The adult version a yellow barrel<br>More information available on how to use :<br>www.epipen.com</div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1978789677/72e5c97ac0d28bd16f45f8ef677bc76c/image.png" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620451</guid>
      </item>
      <item>
         <title>Group 6</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620452</link>
         <description><![CDATA[<div><strong>Epipen</strong><br><strong>CLASS:</strong> Alpha and Beta adrenergic agonists<br><strong>MOA:&nbsp;</strong></div><ul><li>Acts on alpha and beta-adrenergic receptors.&nbsp;</li><li>The strongest alpha receptor activator 	</li><li>Induces:&nbsp;<ul><li>Increased vascular smooth muscle contraction</li><li>Pupillary dilator muscle contraction</li><li>Intestinal sphincter muscle contraction</li><li>Increased heart rate</li><li>Myocardial contractility&nbsp;</li><li>Renin release via beta-1 receptors</li></ul></li></ul><div><strong>Indications for use:</strong> Anaphylaxis, allergic reaction, restoring cardiac rhythm in cardiac arrest, also used as an haemostatic agent.<br><strong>Drug interactions:</strong><br>albuterol, levothyroxine, metformin, seretide<br><strong>Signs &amp; Symptoms: </strong>breathing problems, nausea and vomiting, dizziness, headache, fast irregular or pounding heartbeats, weakness or tremors, pale skin, sweating<br>for DM patient- it can worsen the symptoms for short time<strong><br></strong><br><strong>Nursing considerations to prevent, assess or manage risks:<br></strong>-Monitor HR, cardiac rhythm and RR and urine output<br>-position to upright<br>-educate patient<br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-08-06 05:16:06 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656620452</guid>
      </item>
      <item>
         <title>Group 5</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656941446</link>
         <description><![CDATA[]]></description>
         <enclosure url="" />
         <pubDate>2023-08-07 03:03:17 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656941446</guid>
      </item>
      <item>
         <title>Group 6</title>
         <author>sarahd59</author>
         <link>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656941854</link>
         <description><![CDATA[<div>1.&nbsp; &nbsp; &nbsp; Absorption</div><div>2.&nbsp; &nbsp; &nbsp; Distribution</div><div>3.&nbsp; &nbsp; &nbsp; Metabolism</div><div>4.&nbsp; &nbsp; &nbsp; Elimination</div><div>5.&nbsp; &nbsp; &nbsp; Dosing and development<strong><br></strong><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-08-07 03:04:00 UTC</pubDate>
         <guid>https://padlet.com/sarahd59/pkcedzez5nocz4py/wish/2656941854</guid>
      </item>
   </channel>
</rss>
